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coenzyme A esters of short chain carboxylic acids in
Stefan Weinig,1,2 Hans-Ju¨rgen Hecht,1 Taifo Mahmud,3
and Rolf Mu¨ller1,2,*
1Gesellschaft fu¨r Biotechnologische Forschung
mbH (GBF)
Mascheroder Weg 1
38124 Braunschweig PKSs and amino acids in NRPSs. These precursors are
2 Institut fu¨r Pharmazeutische Biologie attached as thioesters to carrier proteins via a phospho-
Mendelssohnstr. 1 pantetheinyl arm that needs to be transferred posttrans-
Technische Universita¨t lationally to conserved serine residues in each carrier
38106 Braunschweig protein [4]. The selection for each monomer is performed
Germany by acyl transferase domains (AT domains in PKS) and
3 University of Washington adenylation domains (A domains in NRPS). After loading
Department of Chemistry of the megasynthetase, the condensation reactions be-
Seattle, Washington 98195 tween the monomers are catalyzed by ketosynthase
(KS) domains in PKS and by condensation (C) domains
in NRPS, which leads to the formation of carbon-carbon
bonds by Claisen ester condensation and to peptideSummary
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During the last few years, hybrid systems employingA DNA region of 41.847 base pairs from Melittangium
PKS and NRPS biochemistry in the course of the assem-lichenicola Me l46 is shown to be responsible for the
bly of one product have been reported [5–7], which re-biosynthesis of the potent electron transport inhibitor
sulted in intensified studies aimed at the combinationmelithiazol. Melithiazol is formed by a combined poly-
of PKS/NRPS assembly lines for combinatorial biosyn-ketide synthase/peptide synthetase system resembling
thesis [8–10].the myxothiazol megasynthetase from Stigmatella
Although relatively rarely studied in comparison toaurantiaca DW4/3-1. Both natural products share an
actinomycetes, myxobacteria have been shown to be aalmost identical core region but employ different starter
major source of secondary metabolites, especially thosemolecules. Additionally, melithiazol contains a termi-
nal methyl ester instead of the amide moiety found that show the typical features of PKS/NRPS hybrids: the
in myxothiazol. Similar to myxothiazol formation, the incorporation of amino acids and short chain carboxylic
methyl ester is formed via an amide intermediate, which acids into their backbones [11]. Cloning of the responsi-
is converted by a hydrolase and an unusual type of ble genes revealed biosynthetic enzymes that harbor
SAM (S-adenosyl-L-methionine)-dependent methyl- PKS and NRPS modules, even present on one single
transferase into the methyl ester. When transferred open reading frame [12, 13], and a variety of other novel
into the myxothiazol A (amide) producer, these two features have been described from multimodular myxo-
genes lead to the formation of the methyl ester of bacterial systems [14–19]. Cyanobacteria seem to be
myxothiazol. The methyl transferase described is a equally rich in “nonstandard” biosynthetic systems, as
member of a protein subfamily of a previously un- has been shown in recent genetic studies [20–22].
known function lacking a typical SAM binding motif. Myxothiazol [23, 24] and melithiazol [25, 26] represent
two highly efficient electron transport inhibitors of the
eukaryotic respiratory chain which are produced by theIntroduction
myxobacteria Stigmatella aurantiaca DW4/3-1 and Mel-
ittangium lichenicola Me l46, respectively. These com-Polyketide synthases (PKSs) and nonribosomal peptide
synthetases (NRPSs) are important enzymatic systems pounds are similar, but some significant biosynthetic
which are responsible for the formation of an immense differences can be expected due to structural differ-
variety of natural products [1–3]. Starting from simple ences (see Figure 1). The myxothiazol hybrid PKS/NRPS
building blocks, such as short chain carboxylic acids biosynthetic gene cluster was analyzed mainly based
and amino acids, secondary metabolites with various on in silico analysis of the corresponding biosynthetic
biological activities are assembled in microorganisms. The genes [12].
resulting low molecular weight polyketides and polypep- In order to explore the structural diversity and the
tides are widely used by the pharmaceutical and agro- underlying biosynthetic mechanisms as well as the evo-
chemical industry (e.g., erythromycin, rapamycin, FK506, lutionary origin of the biosynthetic machineries, we
cyclosporin, avermectin, lovastatin, and epothilone). cloned and analyzed the melithiazol gene cluster. Bio-
Both PKSs and NRPSs are characterized as large, synthetic origins of the unusual isobutyrate starter unit
multifunctional, and modular enzyme complexes which and the terminal methyl ester in melithiazol as well as
assemble secondary metabolites in a stepwise fashion. the terminal amide in myxothiazol were analyzed using
Their corresponding biosynthetic machineries are inter- classical feeding experiments. Additionally, by heterolo-
gous expression a novel type of SAM-dependent methyl
transferase and a hydrolase are shown to be involved*Correspondence: rom@gbf.de
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Figure 1. Examples for Myxobacterial Secondary Metabolites which Are Biosynthesized by PKS and NRPS
in the methyl ester formation starting from an amide aurantiaca DW4/3-1, M. lichenicola Me l46 uses only
one secondary metabolic Ppant transferase, which mustintermediate.
be encoded outside of the melithiazol biosynthetic gene
cluster.Results and Discussion
Analysis of the modular structure of the melithiazol
megasynthetase revealed that melB most likely encodesCloning and Analysis of the Melithiazol
Biosynthetic Gene Cluster the first module of the biosynthetic gene cluster (see
below). The modular organization of PKSs and NRPSsDue to the structural similarity of myxothiazol and meli-
thiazol, the genes involved in their biosynthesis were involves activation and condensation of the following
carboxylic acid or amino acid onto the growing chainexpected to be similar in sequence. In Southern blot
experiments, it could be shown that genomic DNA of M. catalyzed by an acyl-transferase (AT) domain and a KS
domain (PKS) or an adenylation (A) and a condensationlichenicola Me l46 hybridized under stringent conditions
with mtaE and mtaF gene probes. A cosmid library of (C) domain (NRPS). The resulting -keto acid (oligopep-
tide in NRPS) may subsequently be processed by -keto-M. lichenicola Me l46 was prepared and used for colony
hybridzation experiments, resulting in the identification acyl-reductase (KR) domains, -hydroxy-acyl-dehydra-
tase (DH) domains, and enoyl-reductase (ER) domainsof a cosmid (M1) that gave positive signals with both
probes. End sequences from cosmid M1 (T3 and the T7 or N-methyl transferase (N-MT) and epimerase (E) do-
mains in NRPS (reviewed in [1]). Additional domains forends) were compared to the myxothiazol gene cluster,
revealing M1 to harbor a fragment of the melithiazol C-methylation [29, 30] and O-methylation [12, 18] of
intermediates have recently been reported, and thegene cluster starting with the AT domain of the mtaE
analog melE (see Figure 2A). Using oligonucleotides de- function of heterocyclization (HC) and oxidation (Ox)
domains involved in the formation of oxazoline and thia-signed to bind to this end sequence, cosmid pools of
the gene library were screened for the presence of over- zoline rings and their subsequent oxidation to oxazole
and thiazole structures has been elucidated [3, 31, 32].lapping cosmids [12]. These were subjected to end se-
quencing, and the derived sequences were used to lo- Sequence motifs typical for PKS domains [33, 34] and
NRPS domains [3, 35] were detected in MelB-G (Tablecate the rest of the melithiazol gene cluster on cosmid
M2 (M2 ends in the AT of the mtaF analog melF). Cos- 1 and Figure 2B). The acyl carrier protein domains (ACP)
and the peptidyl carrier protein (PCP) domain of MelB-Gmids M1 and M2 were sequenced and revealed the
presence of several open reading frames (ORFs) with contain the Prosite consensus signature of the putative
binding site for the 4-phosphopantetheine (Ppant) co-similarity to PKSs and NRPS, which were designated
melB-K (melithiazol; see Figure 2A). No gene encoding factor (Prosite signature numbers PS00012, R2082, and
L2104). The codon bias of the genes reported is in accor-a phosphopantetheinyl (Ppant)-transferase similar to
mtaA was found. MtaA was shown to have a broad dance with other genes from myxobacteria [36]. The
overall GC content of the mel-biosynthetic gene clus-substrate specificity [27] and is required for the produc-
tion of myxothiazol [12] and at least two additional PKS ter, which spans approximately 42 kbp, is 69.7%.
Eight further ORFs were identified upstream and down-and PKS/NRPS hybrid compounds produced by S. aura-
ntiaca DW4/3-1 (G. Ho¨fle, S. Wenzel, H. Bode, and R.M., stream of the melithiazol PKS/NRPS genes. Based on
the sequence similarities of the encoded proteins tounpublished data; [28]). It is thus likely that similar to S.
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Figure 2. The mta and mel Biosynthetic Gene Clusters
(A) Comparison of gene arrangements in the mta and mel biosynthetic gene clusters. Arrows indicate the direction of transcription of each
gene. The checkered arrow symbolizes mtaA encoding a phosphopantetheinyl transferase. PKS modules are shown in green, NRPS modules
are shown in red, and ORFs with unknown function are depicted in white. Hatched arrows indicate genes encoding modifying enzymes. PKS,
polyketide synthase; NRPS, nonribosomal peptide synthetase.
(B) Models of myxothiazol and melithiazol biosynthesis. PKS modules are colored in green, NRPS modules are shown in red, and unusual
domains are shown in yellow. Domains depicted in light green are assumed to be derived from each other (see text). The TE domain is shown
in blue. Building blocks incorporated by PKS modules are depicted with green bonds, whereas molecule moieties assembled by NRPS
modules are shown with red bonds. ACP, acyl carrier protein; KS, -ketoacyl-ACP synthase; KR,-ketoacyl-ACP reductase; AT, acyl transferase;
DH, -hydroxy-acyl-ACP dehydratase; O-MT, O-methyl transferase; ER, enoyl reduktase; S, spacer region; PCP, peptidyl carrier protein; C,
condensation domain; HC, heterocyclization domain; A, adenylation domain; Ox, oxidation domain; MOX, monooxygenase domain; TE,
thioesterase.
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Table 1. Deduced Functions of ORFs in the Melithiazol Biosynthetic Gene Cluster
A. PKS and NRPS Parts of the Gene Cluster
Proposed Function
Protein (Gene) Size (bp/Da) (Protein Domains with Their Position in the Sequence)
MelB (melB) 3,153 bp, PKS domains: KS (16-443), AT (555-870), ACP (962-1028)
111,621 Da
MelC (melC) 3,972 bp, NRPS domains: HC (52-452), A (538-1001), PCP (1025-1093) Ox (1025-1093)
146,206 Da
MelD (melD) 9,855 bp, NRPS domains: HC (74-473), A (560-1291), Ox (989-1241), PCP (1319-1383); PKS domains:
357,430 Da KS (1447-1874), AT (1981-2296), DH (2307-2521), S (2612-2849), KR (2882-3134),
ACP (3157-3226)
MelE (melE) 5,739 bp, PKS domains: KS (35-429), AT (573-890), O-MT (972-1246), S (1252-1454), KR (1486-1746),
206,932 Da ACP (1783-1849)
MelF (melF) 4,083 bp, PKS domains: KS (39-464), AT (571-886), O-MT (946-1221), ACP (1272-1338)
148,434 Da
MelG (melG) 5,247 bp, NRPS domains: C (68-367), A (555-1380), MonoOx (753-1114), PCP (1401-1469), TE (1488-1748)
192,469 Da
B. ORFs Encoded Upstream and Downstream of melB-melG
Sequence Similarity to
Proposed Function of the (Source Plus Additional Accession No. of the
Protein (Gene) Size (bp/Da) Similar Protein Available Information) Similarity/Identity Similar Protein
ORF1 (orf1) 699 bp, Similar to glycosyl trans- Archaeoglobus 40%/28% C69298
24,529 Da ferases fulgidus
ORF2 (orf2) 1,359 bp, L-amino acid oxidase Crotalus adamanteus 70%/51% JE0266
48,004 Da
ORF3 (orf3) 963 bp, Nucleotide sugar Escherichia coli WbnF 64%/48% AAD50494
35,377 Da epimerase
ORF4 (orf4) 282 bp, Glutaredoxin Yersinia pestis GrxC 59%/45% NP_403730
10,290 Da
MelH (melH) 990 bp, 2-hydroxyhepta-2,4- Methanothermobacter 56%/40% A69068
36,189 Da diene-1,7-dioate- thermautotrophicus
isomerase MTH1507
MelJ (melJ) 1,088 bp, Nitrilase Arabidopsis thaliana 39%/26% P46010
37,051 Da NIT3
MelK (melK) 906 bp, Methyl transferase Actinosynnema pretio- 41%/28% AF453501.1
33,612 bp sum Asm10
ORF7 (orf7) 1,788 bp ABC-transporter Nostoc punctiforme 61%/44% ZP_00109759
64,332 Da Npun4209
proteins from the databases, ORF2, MelJ, and MelK activated substrate to the first ACP domain (compare
the biosynthetic gene clusters of erythromycin [33], ra-seemed to be involved in the biosynthesis of melithiazol
(see Table 1 and Figures 2A and 4). The gene encoding pamycin [5, 34], and rifamycin [6]). Alternative starters
can be used to initiate the biosynthesis of the polyke-MelH is located directly behind melG, which is similar
to the gene order in the mta gene cluster. Nevertheless, tides, but most frequently acetyl-CoA, malonyl-CoA,
propionyl-CoA, or methylmalonyl-CoA are employed. IfmelH and mtaH do not seem to be required for melithia-
zol and myxothiazol biosynthesis (see the accompa- activated dicarboxylic acids are used, modified KS do-
mains can be found at the beginning of the first module.nying manuscript [65] for a discussion of the putative
function of melH). These have lost their condensation activity but effec-
tively decarboxylate the ACP-bound dicarboxylic acid,
giving rise to the starter moiety. Because the active siteModel for the Melithiazol Biosynthetic Pathway
Here it is demonstrated that the melithiazol biosynthetic cysteine of these KS domains is mutated to glutamine,
they have been designated KSQ domains [37]. In themachinery is very similar to the myxothiazol system and
belongs to the class of hybrid biosynthetic systems case of melB, the modular organization looks similar:
the protein starts with a KS domain that is followed bycomposed of PKS and NRPS modules. The biosynthesis
switches from PKS type biochemistry (MelB) to NRPS an AT and an ACP domain.
Several myxobacterial PKSs show an atypically ar-(MelCD), back to PKS (MelDEF), and finally back to
NRPS (MelG). MelD belongs to the few known proteins ranged starter module with ACP-KS-AT-AT-KR-ACP
[12, 18, 19, 38]. In these systems the first AT loads thein which a NRPS module is covalently linked to a PKS
module, which makes it an ideal target to study PKS/ starter molecule, whereas the second AT loads the first
extender unit ([39]; P. Leadlay, C. Wilkinson, S.W., andNRPS interaction.
The modular structure of type I PKSs usually starts R.M., unpublished data). M. lichenicola Me l46 produces
only melithiazol A (and melithiazol C, which is presum-with an AT or a CoA-ligase domain responsible for the
recognition (and, in the case of CoA-ligases, for activa- ably a degradation product), which is characterized by
a dehydro-isobutyrate starter molecule [26]. Myxobac-tion) of the starter molecule followed by transfer of the
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Figure 3. Models for Amide and Methyl-Ester Formation
(A) Model of terminal amide formation. The glycine used for the extension of myxothiazol acid by MtaG is shown shaded. See text and [12].
(B) Model of methyl-ester formation starting from the amide. The upper route via the imino-ester has been postulated recently [50]. Alternatively,
MelJ might hydrolyze the amide, and MelK could next methylate the free acid (see text).
teria frequently employ activated short branched chain protein most likely involved, because it resembles amino
acid oxidases (see Table 1). The oxidation might takecarboxylic acids as starter molecules for PKS, e.g., iso-
butyrate and 2-methyl-butyrate in myxalamid and isoval- place at any step between the amino acid and the ACP-
bound isobutyrate.erate in myxothiazol biosynthesis [12, 19, 40]. Although
these starter molecules are generally thought to be de- Next, MelC activates cysteine (see Supplemental Ta-
ble S1 at http://www.chembiol.com/cgi/content/full/10/rived from branched chain amino acids by amino acid
degradation, it has recently become clear that in myxo- 10/939/DC1; the A domain perfectly matches the nonri-
bosomal code [43, 44]), performs the first heterocycliza-bacteria a novel branch of the mevalonate pathway is
used as an alternative source of at least isovalerate tion, and transfers the thiazoline-intermediate to MelD.
Interestingly, MelC contains an Ox domain located be-[41]. We expected the dehydro-isobutyrate starter of
melithiazol to be derived from valine degradation and hind the PCP, which is similar to the structure of MtaC.
Nevertheless, M. lichenicola Me l46 is only known tosubsequent oxidation. In order to verify this hypothesis,
d8-DL-valine was fed to the culture broth, and incorpo- produce thiazoline-thiazole type melithiazols, which
raises the question of the function of this Ox domain inration rates of approximately 50% were detected using
LC-MS analysis (melithiazol, MH 423; d5-melithia- both biosynthetic systems. The deletion of the MtaC-Ox
domain leads to a producer of unchanged myxothiazol.zol, M  H  428; data not shown).
The active site cysteine is present in position 189 of Thus, it seems likely that the Ox domains of MtaC and
MelC are superfluous or inactive per se (see accompa-the MelB-KS, which indicates that it does not represent
a KSQ domain. In addition, AT domains located in KSQ- nying manuscript [65]). MelD is similar to MtaD and har-
bors two modules: one NRPS module with another Oxcontaining modules load dicarboxylic acids onto the
PKS. They are known to contain a highly conserved domain that is inserted between the core motifs of A
domains A8 and A9 instead of being localized behindarginine residue [42] that is replaced by a serine in the
MelB-AT. It is thus likely that the MelB-AT domain loads the PCP in MelC. The thiazoline-thiazole intermediate
is then transferred to the PKS module of MelD, whichisobutyryl-CoA onto the ACP. Because there is no indi-
cation from the primary sequence that the MelB-KS is extends with malonate and reduces and dehydrates the
-keto-thioester to its enoyl-form. Large spacer regionsinactive, the function of this domain remains obscure.
It is not clear at which stage of the biosynthesis the (S) are located between the DH and the KR domains of
the PKS module of MelD and between the O-MT andoxidation of the isopropyl moiety occurs; ORF2 is the
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Figure 4. Heterologous Expression of MelK
and MelJ
(A) Schematic diagram showing the chromo-
somal integration of melJK from M. licheni-
cola Me l46 into S. aurantiaca DW4/3-1. Genes
are shown as arrows, and the homologous
region from mtaH used for integration is
hatched (this DNA fragment encodes part of
mtaH and is oriented in the opposite direction
to the rest of the melH gene encoded by
pESW243). P indicates the presumed bidirec-
tional promoter regulating the transcription of
melJK. FspI shows the position of the recog-
nition sequence of the respective restriction
enzyme.
(B) Genotype of the merodiploid strain ESW602
resulting from integration of pESW243 into the
chromosome of S. aurantiaca DW4/3-1.
(C) Southern blot analysis of ESW602 and S.
aurantiaca DW4/3-1 after restriction with
FspI. A DNA fragment containing the pro-
moter region of melJK, melJK, and melH was
used as a probe (3.2 kb). The size of the hy-
bridizing fragments was estimated using DIG-
labeled DNA molecular weight marker III
(Roche Diagnostics). Hybridizing fragments
and their sizes are indicated in (A) and (B). S.
aurantiaca DW4/3-1 chromosomal DNA shows
a signal because mtaH and melH are very
similar on the DNA level (78.6% identity over
680 bp).
KR domains of MelE. These have been described for tion of the enol form of the -keto intermediate bound
to the ACP. Interestingly, the O-MT sequences of MelFalmost all PKS and fatty acid biosynthetic systems [1,
45], but their function is not clear. S regions can also and MtaF show more identity than those of MelE and
MelF (see Supplemental Figure S1B), which suggestsbe found in all myxobacterial PKS systems sequenced
so far and show an identity of up to 35% on the amino that they are specialized for different biochemical reac-
tions.acid level.
MelE is another peculiar enzyme; between the AT do- Unexpectedly, MelG, a MtaG homolog, was found at
the end of the PKS/NRPS part of the gene cluster. MtaGmain and the spacer region an O-MT domain can be
found that has only been reported in two other biosyn- is believed to be involved in the formation of the terminal
amide of myxothiazol (see below). Thus, we expected tothetic systems, both from myxobacteria [12, 18]. This
domain is assumed to methylate the intermediate after find some genes responsible for methyl ester formation,
starting from the thioesterified myxothiazol acid boundketoreduction, giving rise to the methyl ether. The O-MT
domain of MelE is similar to O-MT domains of MelF, to the ACP of MelF. Due to the fact that MelG closely
resembles MtaG, we concluded that melithiazol is formedMtaE, MtaF, StiD, and StiE and shows the typical primary
amino acid sequences involved in SAM binding [46] (see via the amide form of the melithiazol acid. The unusual
mechanism of amide formation by MtaG/MelG is dis-Supplemental Figure S1A at Chemistry & Biology’s web-
site). Feeding experiments employing 13C-labeled methi- cussed in the next paragraph.
onine were performed, the results of which prove that
both O-MT domains employ SAM as cofactor (incorpo- Establishing the Biosynthetic Precursors
of the Terminal Methyl Ester and Amideration rates for the three SAM-derived methyl groups in
melithiazol were between 16% and 21%, see below). The Functionalities by Feeding Experiments
The terminal gene of the myxothiazol gene cluster (mtaG)methylmalonate extended intermediate is transferred to
MelF, which activates malonate. Again, similar biochem- resembles an unusual NRPS with an integrated monoox-
ygenase (MonoOx) domain, which led us to suggest thatistry is performed in comparison to the unique myxothia-
zol system: an O-MT domain gives rise to the methyla- MtaG is involved in the formation of the terminal amide
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Figure 5. Production of Secondary Metabo-
lites in S. aurantiaca DW4/3-1, Mutant ESW602,
and M. fulvus Mx f333/8
HPLC analysis of the extracts from S. auranti-
aca DW4/3-1 (A), mutant ESW602 (B), and the
myxothiazol A and Z producer M. fulvus Mx
f333/8 (C).
via the addition of an extra amino acid to the MtaF- spontaneously (or catalyzed by MtaG), giving rise to
myxothiazol and glyoxylic acid thioesterified to the PCPACP-bound myxothiazol acid. Subsequently, the carbon
backbone of this amino acid is removed by the action of MtaG. The thioesterase at the C terminus of MtaG
would thus be needed to release the glyoxylate fromof the MtaG MonoOx domain, resulting in the terminal
amide structure (see Figure 3; [12]). the PCP to deblock the enzyme.
To strengthen this hypothesis, we tried to identify theTerminal amides are found in many bioactive sub-
stances from mammals and insects, including many nitrogen source of the terminal amide of myxothiazol in a
series of incorporation experiments. The putative donorpeptide hormones [47, 48]. Generally, they arise from
the oxidative cleavage of C-terminal glycine-extended amino acids were chosen after analysis of the MtaG
region responsible for the specificity of A domains forprecursors by a bifunctional copper-zinc-dependent en-
zyme, peptidylglycine -amidating monooxygenase [47, their putative binding pocket [43, 44], which is rather
difficult in MtaG (and MelG as well) due to the insertion48]. The process requires two reaction steps. The first
involves ascorbate- and copper-dependent aerobic hy- of the MonoOx domain next to the binding pocket. Nev-
ertheless, both amino acid regions were indicative ofdroxylation of the glycine -carbon by peptidylglycine
-hydroxylating monooxygenase. The second step, the glycine as the amino acid used (see Supplemental Table
S1 at Chemistry & Biology’s website). We therefore rea-cleavage of the resulting carbinolamide, is catalyzed
by a zinc-dependent enzyme, peptidylamidoglycolate soned that feeding of 15N-labeled glycine should result
in incorporation of the label into myxothiazol. Indeed,lyase. We assumed that the MtaG MonoOx domain
would perform a similar reaction and hydroxylate the using mass spectrometry of isolated myxothiazol, the
result of the feeding experiment showed 40.6% incorpo-amino acid-extended myxothiazol in the  position,
which should result in an intermediate that can fall apart ration of 15N-glycine into the compound (data not shown),
Chemistry & Biology
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whereas 15N-labeled glutamate and ammonium chloride generation of the gene library, presumably due to the
presence of DNases, the strain showed resistancewere not incorporated at all. This suggests that the ter-
minal amide of myxothiazol is derived directly from an against almost every antibiotic tested (kanamycin, hy-
gromycin, streptomycin, apramycin, and tetracyclin).extra glycine that is intermediary attached to the mole-
cule. Interestingly, serine has been shown to be the Few spontaneously resistant colonies were detected
using ampicillin, which encouraged us to try a -lacta-nitrogen source of the terminal amide of nosiheptide
[49], which indicates a similar mechanism for amide mase as marker gene in conjugation and electroporation
experiments aimed at the inactivation of melE. Becauseformation in the producer Streptomyces actuosus and
possibly for other natural products with terminal amide these experiments were not successful, we decided to
heterologously express melithiazol biosynthetic genesmoieties as well (e.g., thiostreptone).
Currently, two more examples of NRPS with inserted in S. aurantiaca DW4/3-1 to unambigously prove that
the right gene cluster was cloned.MonoOx domains can be found in the databases (hypo-
thetical proteins from Nostoc punctiforme and Ralsto- MelK and MelJ seemed to be responsible for the for-
mation of the methyl ester. In addition, earlier studiesnia solanacearum which show the domain structure
A-MonoOx-PCP-KS-AT-ACP-Aminotransferase-C-A- employing M. fulvus Mx f333/8 suggested that myxothia-
zol Z is derived from myxothiazol A via the iminoesterPCP… and …KS-AT-ACP-Aminotransferase-MonoOx-
C-A-PCP…, respectively). None of these proteins seems intermediate (see Figure 3, [50]). Given the structural
analogy between myxothiazol Z and melithiazol A, weto be involved in terminal amide formation, because the
MonoOx domains are not within the C-terminal modules, speculated that melithiazol A is derived from a melithia-
zol-amide analogously, which would employ the imi-nor are they located within an A domain. Nevertheless,
both proteins belong to the class of PKS/NRPS hybrids. noester of the amide as an intermediate (Figure 3). Nev-
ertheless, the amide could not be identified from M.In contrast, the unusual arrangement of domains in
MtaG can be found in MelG as well (see Figure 2B). It lichenicola Me l46. Alternatively, one could speculate
that the methyl ester is formed similarly to the methyla-is thus reasoned that melithiazol in close biosynthetic
analogy is also formed via the amide intermediate. This tion of bacterial chemotaxis transmembrane receptors,
e.g., by the protein methyl transferase CheR and thewould represent a unique mechanism to generate a
methyl ester, because the glycine extender has to be methyl esterase/amidase CheB from Salmonella typhi-
murium [51, 52]. The alternative route would thus involveremoved completely in order to generate the ester. It
seemed likely that melithiazol is biosynthesized by a production of the free myxothiazol acid by MelJ, which
then would have to be methylated (Figure 3). MelJ is amethyl transferase (which would presumably employ
SAM as cofactor) and a hydrolase. The gene products protein with all the hallmarks of the nitrilase superfamily
of proteins, which includes the amidases. The activeof melK and melJ, which are located downstream of
melG, indeed show some similarities to such enzymes site cysteine can be found in position 145 and the cata-
lytic triad glutamate44-lysine112-cysteine145 is responsible(Table 1). To verify the dependence of the methyl ester
formation on a SAM-dependent enzyme, a feeding ex- for hydrolysis [53]. Both possibilities for methyl ester
formation are currently under investigation by heterolo-periment employing [13CH3]methionine was performed
and showed incorporation rates of 16%–21% into the gous expression and purification of MelJ and MelK. The
mechanisms could also be distinguished by feedingthree methoxy-goups of melithiazol A, which was de-
tected using 13C-NMR spectroscopy (data not shown). 13C/18O-labeled acetate. If the former is correct, 18O will
only be present in the methoxyl oxygen; if the latter isSimilar results have been obtained in feeding experi-
ments with Myxococcus fulvus Mx f333/8, the producer correct, then both the methoxyl and carbonyl oxygens
will be labeled so one and two isotope shifts, respec-of the methyl ester of myxothiazol A (designated myxo-
thiazol Z) (see Figure 1; [50]). tively, should be observed on the carbonyl carbon.
In order to verify the involvement of MelK and MelJ in
methyl ester formation, both genes and their presumedHeterologous Expression of the Putative
Methyltransferase MelK and the Hydrolase promoter region were transferred into the myxothiazol
A producer S. aurantiaca DW4/3-1 (see Figure 4). ForMelJ from the Melithiazol Gene Cluster
in the Myxothiazol A Producer homologous recombination, the DNA region of MtaH
was used because this gene is not required for myxothi-M. lichenicola Me l46 proved to be a difficult organism
to work with genetically. After severe problems in the azol formation (see accompanying manuscript [65]).
Figure 6. Alignment of the MelK Subfamily of SAM-Dependent Methyl Transferases
Kagan and Clarke motifs are indicated by red (motif I), green (post I), yellow (motif II), and blue (motif III) triangles. Black triangles indicate
residues binding the SAM cofactor in 1JG4 via side chain atoms, while magenta boxes indicate residues forming the less sequence-specific
backbone or hydrophobic contacts to the cofactor in 1JG4. The absolutely conserved Gly in position 110 in 1JG4 is not in direct contact to
the cofactor. Amino acid sequences used for the alignment were derived from the following organisms (database entries in brackets):
Mycobacterium leprae (Q9X7D5), Homo sapiens LCMT (see text), Caenorhabditis elegans (YKG4_CAEEL), Streptomyces glaucescens
(TCMP_STRGA), Pseudomonas aeruginosa (Q9I2N5), Rhizobium meliloti (Q92Y12), Mycobacterium tuberculosis (YX99_MYCTU), Streptomyces
coelicolor (Q9ZBH0), Actinosynnema pretiosum ASM10 (see text), Streptomyces coelicolor (Q9FBX1), Anabaena sp. (Q8YKG6), Methanosarcina
acetivorans (Q8TLW9), Methanosarcina mazei (Q8PWV7), Mycobacterium tuberculosis (O33293), Oceanobacillus iheyensis (BAC13195), Bacillus
subtilis (Q45500), Arabidopsis thaliana (Q93YR1), Oryza sativa (AAN65019), Rhizobium loti (Q98LR1), Pseudomonas aeruginosa (Q9HX18),
Archaeoglobus fulgibus (PIM1_ARCFU), Methanococcus jannaschii (PIMT_METJA), Pyrococcus horikoshii (PIMT_PYRHO), Aerppyrum pernix
(PIMT_AERPE), and Pyrococcus furiosus (Protein Data Base ID code of methyltransferase 1JG4).
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After transfer of both genes into the myxothiazol pro- conserved, which has already been observed by Martin
and McMillan as common to the methyltransferases.ducer, the genotype of the mutant strain was analyzed
by Southern hybridizations verifying the correctness of The absolutely conserved Gly in position 110 in 1JG4 is
not in direct contact with the cofactor, but on one sidethe integration in mutant ESW602 (Figure 4). HPLC-MS
analysis of ESW602 culture broth revealed the presence of the binding pocket. It is located in a position where
any amino acid side chain would interfere with the cofac-of myxothiazol A and myxothiazol Z (see Figure 5; LC-
MS analysis: myxothiazol A, M H  503; myxothiazol tor sulfur atom. Thus, it can be expected that MelK, as
Asm10 and LCMT, binds the SAM-cofactor similarly toZ, M  H  488), which clearly establishes that MelK
and MelJ are responsible for the transformation of the the other methyltransferases and contains the typical
SAM binding fold.-methoxyacrylate amide into the -methoxyacrylate
ester.
Evolutionary Aspects of Melithiazol
and Myxothiazol BiosynthesisMelK Is a SAM-Dependent Methyl Transferase
It is interesting to note that the myxothiazol gene clusterwith Poorly Conserved SAM Binding Site
must have evolved from the melithiazol gene cluster orSearches for MelK homologs in Swall using Fasta3 [54]
vice versa, which can be shown by sequence compari-gave 41 related proteins, mostly from mycobacteria,
son (Figure 2); MelC-H and MtaC-H are highly homolo-streptomyces, and methanosarcina with unknown func-
gous (the encoding genes are very similar in sequencetion, as well as the methyltransferase Asm10 from the
as well; see Figure 2) and are presumed to have similarActinosynnema pretiosum ansamitocin biosynthetic
functions in melithiazol and myxothiazol biosynthesis.gene cluster [55]. Asm10 is the only biochemically char-
Even the large identical repeat within the AT of mtaDacterized member of this group of proteins. The recom-
and mtaF (1223 bp, 99.7% identity) is found in melD andbinant enzyme catalyzes the final step in ansamitocin
melF as well (1222 bp, 99.1% identity). Unexpectedly,biosynthesis, the SAM-dependent N-methylation of the
when the mel and mta repeat regions are compared,amide linkage (G. Shang, P. Spiteller, L. Bai, B.J. Carroll,
they are not identical and do not show higher similaritiesT.-W. Yu, and H.G. Floss, personal communication). No
with each other than the complete genes. MtaB andsignificant similarities to structurally known SAM-depen-
MelB are involved in the formation of the PKS starterdent methyl transferases specific either for small mole-
molecule, which is different in both biosyntheses. Ac-cule, protein, DNA, or RNA were detected initially. For
cordingly, the corresponding genes show lower similar-these, it has been demonstrated that they share only
ity scores. Nevertheless, the KS-AT-ACP fragment oflittle sequence identity but contain a highly conserved
the second module of MtaB clearly resembles MelB. Allstructural fold with the poorly conserved SAM binding
the other KS, AT, and ACP domains of the myxothiazolresidues [56]. In contrast to the O-MT domains of MelE
gene cluster are much less similar to those of MelBand MelF, which match the formerly proposed core
(Figure 2). This suggests that MelB evolved from MtaBsequences perfectly (see Supplemental Figure S1 at
by deletion of the reductive loop of the second module ofChemistry & Biology’s website; [46]), these signature
MtaB accompanied by the additional loss of the loadingsequences are difficult to identify in MelK and the related
module and the first module of MtaB. Alternatively, do-sequences. A brain protein phosphatase 2A leucine car-
main and module insertions might have caused the gen-boxyl methyltransferase (LCMT) uses SAM as cofactor.
eration of MtaB from MelB. Unexpectedly, no similaritiesIt harbors four regions that coincide fairly well with the
were found in the sequences flanking the PKS/NRPSKagan and Clarke binding motifs I–III and the additional
regions. No similar genes to mtaA and ORFA are locatedpost I motif [57]. However, a profile fitting alignment of
upstream and downstream of the mel region in M. li-the MelK-related sequences with the protein-L-isoas-
chenicola Me l46.partate O-methyltransferase from Pyrococcus furiosus
(Protein Data Bank ID code 1JG4) and other sequences
from the Pimt branch of SAM-dependent methyltransfer- Significance
ases (EC 2.1.1.77) shows reasonable similarity of the
motifs identified by Kagan and Clarke in the MelK- Myxobacteria are a rich source of secondary metabo-
lites with biological activity. In contrast to actinomy-related sequences, making it plausible to include these
enzymes in the large family of SAM-dependent methyl- cetes, molecular analyses of biosynthetic systems are
rare, and genetic systems are still lacking for mosttransferases. Figure 6 shows an alignment of MelK and
related proteins from diverse organisms together with myxobacterial genera. Nevertheless, a considerable
variety of hybrid PKS/NRPS compounds from myxo-some typical Pimt methyltransferases. The Kagan and
Clarke motifs are indicated by red (motif I), green (post bacteria makes the corresponding biosynthetic ma-
chineries very interesting targets to study. The melithi-I), yellow (motif II), and blue (motif III) triangles. Black
triangles indicate residues binding the SAM cofactor in azol PKS/NRPS hybrid described in this publication
has been analyzed because of the effectiveness of the1JG4 via side chain atoms, which are therefore se-
quence specific, while magenta boxes indicate residues compound as inhibitor of the eukaryotic respiratory
chain. In addition, the availability of the gene clusterforming less sequence specific backbone or hydropho-
bic contacts to the cofactor in 1JG4. Two of the four allows the comparison with the myxothiazol system,
which is similar but shows significant biosynthetic dif-residues forming side chain contacts to the cofactor
in 1JG4 display conservative amino acid substitutions ferences. Considerable information can be gained
about unusual domains in PKS and NRPS, e.g., O-methyl(Gly/Ala 108 and Glu/Asp 128); all other residues are not
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harboring single colonies were picked into 96-well microtiter plates,transferase domains embedded in PKS and oxidase
grown in LB medium overnight, and replicated twice. Twenty-fiveand monooxygenase domains embedded in NRPS.
percent glycerol was added to one copy of the library, and theThe formation of the terminal amide of myxothiazol is
plates were frozen at 80C. The colonies of the second copy were
clearly NRPS dependent, and glycine has been estab- transferred onto a nylon membrane (Biodyne B, Pall), which was
lished as the nitrogen source. This is presumably a used for the colony hybridization. Cell mass of 16 clones of each
plate of the third copy was collected, and cosmid DNA from eachgeneral mechanism for amide formation in bacteria.
“pool” was prepared. These “cosmid pools” were used as templatesUnexpectedly, the mechanism of methyl-ester forma-
in PCR reactions with primer pair MEL1, 5-ATC CGG GTC TTC GCGtion in melithiazol biosynthesis involves the amide in-
CGC GAC A-3 and MEL3L, 5-GGA TCC TCC AGG AAG AGC GAGtermediate as well. Heterologous expression of MelK
G-3, which were designed to specifically bind to the insert located
and MelJ results in the formation of the methyl ester at the T7 end of cosmid M1. DNA of single cosmids from the pools
of myxothiazol. MelK belongs to a new subclass of giving a PCR product of the expected size (350 bp) were used as
templates in a second round of PCR. Positive clones were furtherSAM-dependent methyl transferases with low homol-
analyzed by Southern blot hybridization using probes derived fromogy to the typical SAM binding motif. Most proteins
the mta gene cluster. Additionally, these cosmids were end se-of the same subclass have a unknown function and
quenced, and the derived sequences were compared with the se-might be involved in regulation processes, e.g., via
quence of the mta gene cluster.
protein methylation.
Production and Analysis of Secondary Metabolites
Experimental Procedures in S. aurantiaca DW4/3-1 and Its Descendants
The cultivation of the strains, the preparation of the culture extracts,
Bacterial Strains and Culture Conditions and the conditions for the analysis of the spectrum of secondary
Escherichia coli and S. aurantiaca DW4/3-1 and its descendants metabolites using diode array-coupled HPLC were desribed pre-
were cultured as described previously [12, 58]. M. lichenicola Me viously [12]. A solvent gradient was applied using 0.2% aqueous
l46 was cultivated in M7 liquid medium containing probion ME 0.5%, acetic acid (solvent A) and acetonitrile (solvent B): 50% B at 0 min
CaCl2  2 H2O 0.1%, MgSO4  7 H2O 0.1%, yeast extract 0.1%, to 70% B at 15 min. Subsequently, the percentage of solvent B was
soluble starch 0.5%, and HEPES buffer 50 mM (pH 7.2). One hundred increased in a gradient up to 100% within 1 min. The flow rate was
milliliter cultures in 250 ml Erlenmeyer flasks were incubated at 30C 0.5 ml/min while detection was carried out at 254 nm.
on a gyratory shaker at 160 rpm for 4–5 days.
Heterologous Expression of melJ and melKDNA Manipulations, Analysis, Sequencing, and PCR
Hydrolysis of cosmid M1 with StuI yields four DNA fragments withChromosomal DNA from S. aurantiaca DW4/3-1 and M. lichenicola
sizes between 3.1 and 3.2 kb. The target fragment harbors at its 5Me l46 was prepared as described [59]. Southern Blot analysis of
end a 309 bp deletion of melH and the complete genes melJ andgenomic DNA was performed using the standard protocol for homol-
melK. Additional 670 bp in front of melK presumably harbor theogous probes of the DIG DNA labeling and detection kit (Roche
promoter region regulating the transcription of melJK (Figure 4). ForDiagnostics, Mannheim, Germany).
heterologous expression of melJ and melK in S. aurantiaca DW4/Sequencing of cosmids M1 and M2 was performed by a shotgun
3-1, the mixture of four fragments was subcloned into pCR-XL-approach: sheared fragments of the two cosmids were subcloned
TOPO (Invitrogen) after restriction of cosmid M1 and extension ofseparately into pTZ18R. About 500 clones were selected from each
the fragments using Taq-DNA-polymerase. Clones were analyzed bycosmid library, and plasmid DNA was prepared (Millipore) and se-
restriction and sequencing, resulting in the identification of plasmidquenced using DYEnamic ET terminator cycle sequencing premix
pMSW12 harboring the 3264 bp target fragment. To allow homolo-kit (Amersham Pharmacia Biotech) and UPO/PRO primers (MWG-
gous recombination in S. aurantiaca DW4/3-1 via mtaH, the insertBiotech). The gels were run on ABI-377 sequencers, and data were
of pESW26 (532 bp PCR-product generated using primers E3 andassembled and edited using the XGAP program [60].
E4 from cosmid E201 [12] and cloned into pCR-2.1-TOPO) wasPCR was carried out using Pfu-DNA-Polymerase (Stratagene) ac-
isolated after digestion with NotI/SpeI and cloned into NotI/XbaIcording to the manufacturer’s protocol with the addition of 5%
predigested pMSW12, which resulted in pESW243. This plasmidDMSO. Conditions for amplification with the Eppendorf Mastercy-
was transferred into the chromosome of S. aurantiaca DW4/3-1 bycler gradient (Eppendorf, Germany) were as follows: denaturation
homologous recombination as described previously [12], and thefor 30 s at 95C, annealing for 30 s at 60C, and extension for 45 s
mutants were analyzed as described in the accompanying manu-at 72C, 30 cycles and a final extension at 72C for 10 min. Primers
script [65].used for the amplification of internal fragments of mtaH were E3,
5-TCG GCA GGA AGA AGT CGT C-3 and E4, 5-CTC GGG ATC
Feeding Experiments Employing Labeled PrecursorsCAG CAG GTA G-3.
[13CH3]MethionineAll other DNA manipulations were performed according to stan-
One liter of M7 medium in 2 l Erlenmeyer flasks was inoculated withdard protocols [61]. Amino acid and DNA alignments were done
50 ml of 3-day-old M. lichenicola Me l46 culture and grown at 30Cusing the programs of the Lasergene software package (DNAstar
(170 rpm in a gyratory shaker). Ten milligrams of [13CH3]methionineInc.) and ClustalW [62].
(Campro Scientific) was dissolved in 10 ml water and sterilized using
a membrane filter. The compound was pulse fed as follows: 6 mgColony Hybridization
after 24 hr, 2 mg each after 48 and 72 hr. One percent (v/v) XAD-Colony Hybridization was carried out according to the manufactur-
adsorber resin (Rohm & Haas) was added after 72 hr. After incubat-er’s protocol (Roche Diagnostics, Mannheim) under stringent condi-
ing for 96 hr, cells and resin were harvested by centrifugation, andtions. Screening probes were derived from mtaE and mtaF (oligonu-
the pellet was extracted and analyzed as described by 13C-NMR [26].cleotides METE1FOR 5-CAG AGC TCG AGG TCA TGT TGC AGT
Incorporation rates were calculated by comparison to an internalCGC-3 and METE4REV 5-GCT CTA GAT GAG CCC GAA GCG CTT
standard.GGA C-3 were used to generate the probe derived from mtaE, and
d8-DL-Valineprimer pair SW1 5-AGG TGG GGC CGA AGC CGA CGT TG-3 
Fifty milliliters of M7 medium in 250 ml Erlenmeyer flasks was inocu-SW4 5-GGA TGC CGT GCA GGT GCT TCT-3 was used to generate
lated with 2 ml of a culture of M. lichenicola Me l46 (3 days old) andthe probe derived from mtaF). Cosmid M1 hybridized with both
grown at 30C (170 rpm in a gyratory shaker). Fifteen milligramsprobes.
of deuterated d8-DL-Valine (Cambridge Isotope Laboratories) was
added at 24 hr, 48 hr, and 72 hr. After 72 hr, XAD-adsorber resinPreparation and Screening of the Cosmid Library
was added (1% [v/v]), and cells were grown for another 24 hr. Subse-The cosmid gene library of M. lichenicola Me l46 was made as
described for S. aurantiaca Sg a15 [63]. Approximately 1900 cosmid- quently, cells and resin were harvested by centrifugation and ex-
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tracted twice (first using 30 ml methanol and then with 20 ml ace- 7. Gehring, A.M., DeMoll, E., Fetherston, J.D., Mori, I., Mayhew,
tone). Combined extracts were dried under vacuo and redissolved G.F., Blattner, F.R., Walsh, C.T., and Perry, R.D. (1998). Iron
in 500 	l methanol. The analysis was performed after injection of 5 acquisition in plague: modular logic in enzymatic biogenesis of
	l of the extract into a HPLC-MS Agilent 1100 LC system. The yersiniabactin by Yersinia pestis. Chem. Biol. 5, 573–586.
following solvents were used: A, 5% acetonitrile, 95% water, 5 mM 8. O’Connor, S.E., Chen, H.W., and Walsh, C.T. (2002). Enzymatic
ammonium acetate (NH4Ac), 0.003% acetic acid; B, 95% acetonitrile, assembly of epothilones: The EpoC subunit and reconstitution
5% water, 5 nM NH4Ac, 0.003% acetic acid. A solvent gradient was of the EpoA-ACP/B/C polyketide and nonribosomal peptide in-
applied as follows: 10% B at 0 min to 100% B within 30 min, then terfaces. Biochemistry 41, 5685–5694.
10 min with 100% B. The flow rate was 0.3 ml/min and the UV 9. Admiraal, S.J., Khosla, C., and Walsh, C.T. (2002). The loading
detection was carried out at 220 nm. For mass detection, a PE Sciex and initial elongation modules of rifamycin synthetase collabo-
API 2000 mass spectrometer equipped with a TurbolonSpray source rate to produce mixed aryl ketide products-1. Biochemistry 41,
was used. 5313–5324.
15N-Glycine, 15N-Glutamate, and 15N-Ammonium Chloride 10. Cane, D., and Walsh, C. (1999). The parallel and convergent
S. aurantiaca DW 4/3-1 was inoculated in 20 ml tryptone-starch universes of polyketide synthases and nonribosomal peptide
medium [41] and cultivated at 28C (200 rpm in a gyratory shaker)
synthetases. Chem. Biol. 6, R319–R325.
for 2 days. Ten milliliters of the culture was then transferred to a
11. Reichenbach, H., and Ho¨fle, G. (1999). Myxobacteria as produc-
500 ml erlenmeyer flask containing 200 ml tryptone-starch medium,
ers of secondary metabolites. In Drug Discovery from Nature,
and the flask was shaken at 30C (160 rpm). Thirty milligrams of
S. Grabley and R. Thieriecke, eds. (Berlin: Springer Verlag), pp.each of the labeled precursors (15N-Glycine, 15N-glutamate, and
149–179.15N-ammonium chloride) was dissolved in 2 ml water and sterilized
12. Silakowski, B., Schairer, H.U., Ehret, H., Kunze, B., Weinig, S.,through a 0.22 	m diameter pore size ultrafilter (Millipore, Millex-
Nordsiek, G., Brandt, P., Blo¨cker, H., Ho¨fle, G., Beyer, S., et al.GV4). The labeled precursors were pulse fed in two equal portions
(1999). New lessons for combinatorial biosynthesis from myxo-24 and 48 hr after inoculation. Cells were harvested after 4 days of
bacteria: the myxothiazol biosynthetic gene cluster of Stig-cultivation, and the products were extracted with acetone. Myxothi-
matella aurantiaca DW4/3–1. J. Biol. Chem. 274, 37391–37399.azol was purified by silica gel column chromatography (n-hex:EtOAc
13. Paitan, Y., Alon, G., Orr, E., Ron, E.Z., and Rosenberg, E. (1999).5:1  n-hex-EtOAc 1:1, EtOAc) and subsequently by HPLC (YMC-
The first gene in the biosynthesis of the polyketide antibioticPack ODS-AQ, 250 10 mm, methanol:water 82:18). The incorpora-
TA of Myxococcus xanthus codes for a unique PKS moduletion rate of 15N into myxothiazol was determined using single ion
coupled to a peptide synthetase. J. Mol. Biol. 286, 465–474.monitoring in a electrospray mass spectrometer [64].
14. Molnar, I., Schupp, T., Ono, M., Zirkle, R.E., Milnamow, M.,
Nowak-Thompson, B., Engel, N., Toupet, C., Stratman, A., Cyr,
D.D., et al. (2000). The biosynthetic gene cluster for the microtu-Acknowledgments
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